Mariangela Allocca © ECCO

The 73rd ECCO Educational Workshop was held in Bucharest, Romania, on September 23, 2023. The workshop focused in the first session on specific clinical scenarios, including the management of acute severe ulcerative colitis, complicated Crohn's disease, and postoperative monitoring, and then addressed challenging and hot topics in the second session, such as treatment escalation and de-escalation and drug-associated side effects.  The interest of the topics covered stimulated several interactive discussions, providing a platform for networking and exchange of innovative ideas.

Natália Queiroz © ECCO

The 72nd ECCO Educational Workshop occurred in Cartagena, Colombia, on September 14th, 2023, uniting participants from Colombia, Ecuador and Peru. The workshop featured interactive discussions on different clinical scenarios emphasizing the multidisciplinary approach and state-of-the-art lectures on hot topics in IBD.

Pascal Juillerat  © ECCO

Dear ECCO Members,

Greetings to you and your families! I am sure you are all looking forward to the holidays and spending some quality time with all your loved ones.

Here is a recap to the changes made to the e-Learning platform this year: we have added new and exciting content for you to browse through, including the updated the e-Library with all the latest Abstracts and Presentations from the ECCO’23 Congress, and to check out a list of specially curated list recorded Educational Courses.

At the upcoming ECCO’24 Congress in Stockholm, the Epidemiological Committee (EpiCom) will hold its 7^th Workshop on Wednesday, February 21.

In the dynamic landscape of healthcare, patients are now assuming a pivotal role beyond their traditional status as care recipients. They are emerging as active partners, capable of contributing invaluable insights to medical research. The theme of the 7^th EpiCom Workshop will be "The patient as an Epidemiologist", and the workshop will aim to shed light on the empowering potential of patient involvement, underscoring the significance of utilising appropriate tools to assess clinically relevant outcomes. Moreover, it will emphasise the pivotal role of digital tools in enabling patients to directly contribute to the research process.

Shaji Sebastian  © ECCO

Murat Toruner © ECCO

In the past, IBD was believed to be predominantly a disease of the Western world. However, recent studies have shown a rapidly increasing incidence of IBD in newly developing areas such as the Middle East, South America and Asia. By the middle of this century, the prevalence of IBD in low and lower-middle income countries (LLMICs) and newly industrialised nations may surpass that in the West. At the same time, the compound prevalence in the Western world and increasing health care costs will add to the challenges in IBD care. As a result of these epidemiological trends, IBD is projected to be an increasing global health burden.

Alicja Ewa Ratajczak-Pawłowska © Alicja Ewa Ratajczak-Pawłowska

As a result of my D-ECCO Travel Award, I was able to spend time at the San Filippo Neri Hospital in Rome during January 2023. There I collaborated with a team at the IBD Unit, UOC Gastroenterology. During my stay, I summarised the studies on nutritional determinants of bone mineral density among patients with Crohn’s Disease and Ulcerative Colitis which my colleagues and I had conducted in the previous year. I collected data from food frequency questionnaires and laboratory tests, including with respect to calcium, vitamin D, folic acid and homocysteine levels. Additionally, I started planning future research on the impact of MTHFR gene polymorphism on folic acid and homocysteine status and on bone mineral density in patients suffering from IBD. I also had the opportunity to learn about the standard of care for IBD patients in Italy.

Deciphering the bioactive role of extracellular matrix fragments (matrikines) in Crohn's Disease (CD) fibrostenosis as potential therapeutic targets and biomarkers

Margarita Papatheodoridi   © Margarita Papatheodoridi

Background & aim of research

To evaluate the in vitro effect of selected novel matrix-derived peptides (matrikines) that specifically appear in the intestinal tissue of patients with Crohn’s Disease (CD) fibrostenosis on primary human intestinal myofibroblasts (iMFBs).

The gut mycobiome in Inflammatory Bowel Disease

Continuation of the project initiated by Chloe Huseyin, ECCO Grant Awardee

Marcus Claesson   © Marcus Claesson

Background & aim of research

The conducted research had two aims:

Aim 1: To characterise the inter-/intra-individual composition of the mycobiome of patients with IBD and healthy controls utilising a variety of sample types and methodological techniques.

Aim 2: To provide a large dataset of fungal internal transcribed spacer (ITS) rRNA sequencing data to complement the bacterial 16S rRNA analysis underway in-house.

Intestinal epithelial cell stress modulates enteric fibroblastic and neuronal profiles in Inflammatory Bowel Disease

Neil Chanchlani  © Neil Chanchlani

Background & aim of research

Multiple patient, disease and pharmacokinetic (including anti-TNF drug and antibody concentrations) factors, as well as a limited number of proteomic markers, have been implicated in anti-TNF treatment failure. However, their relative effects and interactions have not been fully explored. We aimed to replicate previously postulated serological markers and to identify novel inflammatory and immune response proteomic markers related to anti-TNF treatment failure in patients with active luminal Crohn’s Disease.

Intestinal epithelial cell stress modulates enteric fibroblastic and neuronal profiles in Inflammatory Bowel Disease

C. Escudero-Hernández © C. Escudero-Hernández

Background & aim of research

This project aimed to understand the effects that crucial IBD epithelial stress factors (i.e. ATG16L1 and XBP1 impairments) might have in enteric fibroblasts and neurons.